Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patients.

Abstract

AIM Tumor gene-expression profiling may define signatures capable of discriminating between responders and nonresponders to chemotherapy. PATIENTS & METHODS Fifty seven metastatic colorectal cancer patients were prospectively included and 40 tumors were analyzed. Patients were treated in first line with 5-fluorouracil associated with irinotecan or… (More)
DOI: 10.2217/pgs.11.174

Topics

Cite this paper

@article{LarocheClary2012AbsenceOT, title={Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patients.}, author={Audrey Laroche-Clary and Audrey Kauffmann and D. Scott Smith and Armelle Laurand-Quancard and S M Evrard and R. C. Brunet and Val{\'e}rie Le Morvan and Jacques Robert}, journal={Pharmacogenomics}, year={2012}, volume={13 4}, pages={497-504} }